Evaluating Relative Bioavailability of OC-01 (Varenicline) Nasal Spray as Compared to Orally Administered Varenicline
Clinical trial NCT04072146 · COMPLETED
Trial details
- NCT number
- NCT04072146
- Sponsor
- Oyster Point Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-26
- Primary completion
- 2019-11-15
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.